Venlafaxine Teva

Leaflet attached to the packaging: information for the user

Venlafaxine Teva, 37.5 mg, prolonged-release, hard capsules

Venlafaxine Teva, 75 mg, prolonged-release, hard capsules

Venlafaxine Teva, 150 mg, prolonged-release, hard capsules

Venlafaxine

You should carefully read the contents of the leaflet before using the medicine, as it contains important information for the patient.

• You should keep this leaflet, so that you can read it again if you need to.
• If you have any further questions, you should ask your doctor or pharmacist.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm them, even if their symptoms are the same as yours.
• If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. See section 4.

Table of contents of the leaflet

• 1. What is Venlafaxine Teva and what is it used for
• 2. Important information before taking Venlafaxine Teva
• 3. How to take Venlafaxine Teva
• 4. Possible side effects
• 5. How to store Venlafaxine Teva
• 6. Contents of the packaging and other information

1. What is Venlafaxine Teva and what is it used for

Venlafaxine Teva contains the active substance venlafaxine.
Venlafaxine Teva is an antidepressant that belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRI). This group of medicines is used to treat depression and other conditions, such as anxiety disorders. It is believed that people with depression and/or anxiety disorders have lower levels of serotonin and norepinephrine in the brain. The mechanism of action of antidepressants is not fully understood, but they may help by increasing the concentration of serotonin and norepinephrine in the brain.
Venlafaxine Teva is used to treat depression in adults. It is also indicated for the treatment of the following anxiety disorders in adults: generalized anxiety disorder, social phobia (fear or avoidance of social situations), and panic disorder (panic attacks). For the patient to feel better, it is essential that the treatment of depression and anxiety disorders is carried out properly. If left untreated, the patient's condition may not improve, may worsen, and will be much more difficult to cure.

2. Important information before taking Venlafaxine Teva

When not to take Venlafaxine Teva

• if you are allergic to venlafaxine or any of the other ingredients of this medicine (listed in section 6).
• if you are taking or have taken within the last 14 days certain medicines called irreversible monoamine oxidase inhibitors (IMAOs) used to treat depression or Parkinson's disease. Taking irreversible IMAOs with Venlafaxine Teva can cause serious or even life-threatening side effects. Also, before starting to take any IMAO medicine, you should wait at least 7 days after stopping Venlafaxine Teva (see also "Venlafaxine Teva and other medicines" and the information in this section on serotonin syndrome).

Side effects can be serious. Also, before starting to take any IMAO medicine, you should wait at least 7 days after stopping Venlafaxine Teva (see also "Venlafaxine Teva and other medicines" and the information in this section on serotonin syndrome).

Warnings and precautions

Before taking Venlafaxine Teva, you should discuss with your doctor:

• if you are taking other medicines that may increase the risk of serotonin syndrome when taken with Venlafaxine Teva (see "Venlafaxine Teva and other medicines")
• if you have eye diseases, such as certain types of glaucoma (increased pressure in the eyeball)
• if you have had high blood pressure in the past
• if you have had heart disease in the past
• if you have had irregular heart rhythms
• if you have had seizures (epilepsy) in the past
• if you have had low sodium levels in the blood (hyponatremia) in the past
• if you have a tendency to bruise or bleed (bleeding disorders in the past), if you are taking other medicines that may increase the risk of bleeding, e.g., warfarin (used to prevent blood clots), or if you are pregnant (see "Pregnancy and breastfeeding")
• if you or anyone in your family has had mania or bipolar affective disorder (feeling excessively excited or euphoric) in the past
• if you have had aggressive behavior in the past.

Venlafaxine Teva may cause feelings of restlessness or inability to sit or stand still in the first few weeks of treatment. If such symptoms occur, you should inform your doctor.
Do not drink alcohol while taking Venlafaxine Teva, as it may cause extreme fatigue and loss of consciousness. Taking it with alcohol and/or certain medicines may increase the symptoms of depression and other conditions, such as anxiety disorders.
Suicidal thoughts and worsening of depression or anxiety disorders
Patients with depression and/or anxiety disorders may sometimes have thoughts of self-harm or suicide. Such thoughts may increase when starting antidepressant treatment, as these medicines usually start working after about 2 weeks, sometimes later. These thoughts may also occur when reducing the dose or stopping Venlafaxine Teva treatment.
Suicidal thoughts are more likely to occur if:

• you have had suicidal thoughts or self-harm in the past
• you are a young adult. Clinical trial data indicate an increased risk of suicidal behavior in young adults (under 25 years of age) with mental disorders treated with antidepressants.

If you experience suicidal thoughts or self-harm, you should immediately contact your doctor or go to the hospital.
It may be helpful to inform your family or friends about your depression or anxiety disorder and ask them to read this leaflet. You can ask your family or friends to help you and tell you if your depression or anxiety gets worse, or if you experience any worrying changes in your behavior.
Dry mouth
Dry mouth has been reported by 10% of patients treated with venlafaxine. This may increase the risk of tooth decay. Therefore, you should pay special attention to oral hygiene.
Diabetes
Blood glucose levels may change while taking Venlafaxine Teva. Therefore, it may be necessary to adjust the dosage of antidiabetic medicines.
Sexual dysfunction
Medicines like Venlafaxine Teva (SNRI) may cause sexual dysfunction (see section 4). In some cases, these symptoms have persisted after stopping treatment.
Pellets in the stool
Do not worry if you see small, white balls or granules in your stool after taking this medicine. The capsules of Venlafaxine Teva contain spheroids (small white balls) that contain the active substance (venlafaxine). These balls are released from the capsule into the stomach. As they pass through the stomach and intestines, venlafaxine is slowly released. The spheroid "shell" does not dissolve and is excreted in the stool. Therefore, even if the spheroids are visible in the stool, the dose of the medicine has been absorbed.

Children and adolescents

Venlafaxine Teva should not normally be used in children and adolescents under 18 years of age.
It should be noted that in the case of taking medicines of this class, patients under 18 years of age are at increased risk of side effects, such as suicidal attempts, suicidal thoughts, and hostility (especially aggression, rebellious behavior, and expressions of anger). Nevertheless, the doctor may prescribe Venlafaxine Teva to patients under 18 years of age, considering that it is in their best interest. If the doctor prescribes Venlafaxine Teva to a patient under 18 years of age and there are any doubts, you should consult the doctor. You should inform the doctor if a patient under 18 years of age taking Venlafaxine Teva experiences or worsens any of the symptoms mentioned above. There is also a lack of available data on the long-term safety of using this medicine in this age group regarding growth, maturation, and cognitive and behavioral development.

Venlafaxine Teva and other medicines

You should tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as any medicines you plan to take.
Your doctor will decide whether to use Venlafaxine Teva with other medicines.
Do not start or stop taking other medicines, including those available without a prescription, herbal or natural remedies, without consulting your doctor or pharmacist first.

• Monoamine oxidase inhibitors, which are used to treat depression or Parkinson's disease should not be taken with Venlafaxine Teva. You should inform your doctor if you have taken these medicines in the last 14 days. (IMAO: see "Important information before taking Venlafaxine Teva")
• Serotonin syndrome:During venlafaxine treatment, a life-threatening or neuroleptic malignant syndrome (NMS) may occur, especially when taken with other medicines (see section "Possible side effects").

Examples of such medicines include:

• triptans (used to treat migraine headaches)
• other medicines used to treat depression, such as selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, or lithium-containing medicines
• medicines containing amphetamine derivatives (used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity)
• medicines containing the antibiotic linezolid (used to treat infections)
• medicines containing the MAO inhibitor moclobemide (used to treat depression)
• medicines containing sibutramine (used for weight loss)
• medicines containing opioids (e.g., buprenorphine, tramadol, fentanyl, tapentadol, pethidine, or pentazocine) used to treat severe pain
• medicines containing dextromethorphan (used to treat cough)
• medicines containing methadone (used to treat opioid addiction or severe pain)
• medicines containing methylene blue (used to treat high methemoglobin levels in the blood)
• medicines containing St. John's Wort ( Hypericum perforatum, herbal or natural remedies used to treat mild depression)
• medicines containing tryptophan (used for sleep problems and depression)
• antipsychotic medicines (used to treat conditions with symptoms such as hearing, seeing, or feeling things that are not there, delusions, unnatural suspicion, unclear reasoning, and withdrawal)

The subjective and objective symptoms of serotonin syndrome may include the following symptoms: restlessness, hallucinations, loss of coordination, rapid heart rate, elevated body temperature, rapid changes in blood pressure, overreactivity, diarrhea, coma, nausea, vomiting.
The most severe form of serotonin syndrome can resemble neuroleptic malignant syndrome. Its symptoms include: fever, rapid heart rate, sweating, muscle stiffness, disorientation, increased muscle enzyme levels (detected in a blood test).

If serotonin syndrome is suspected, you should immediately tell your doctor or go to the emergency department of the nearest hospital.

You should inform your doctor if you are taking medicines that may affect heart rhythm.
Examples of such medicines include:

• anti-arrhythmic medicines, such as quinidine, amiodarone, sotalol, or dofetilide (used to treat heart rhythm disorders)
• antipsychotic medicines, such as thioridazine (see also "Serotonin syndrome" above)
• antibiotics, such as erythromycin or moxifloxacin (used to treat bacterial infections)
• antihistamines (used to treat allergies)

The following medicines may also interact with Venlafaxine Teva and should be used with caution. It is especially important to inform your doctor if you are taking medicines containing:

• ketoconazole (an antifungal medicine)
• haloperidol or risperidone (medicines used to treat mental disorders)
• metoprolol (a beta-blocker used to treat high blood pressure and heart disease)

Venlafaxine Teva with food, drink, and alcohol

Venlafaxine Teva should be taken with food (see section 3 "How to take Venlafaxine Teva").
Do not drink alcohol while taking Venlafaxine Teva. Taking it with alcohol may cause extreme fatigue and loss of consciousness, as well as increase the symptoms of depression and other conditions, such as anxiety disorders.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine. Venlafaxine Teva should only be used after consulting your doctor about the potential benefits and risks to the unborn child.
You should inform your doctor and/or midwife about taking Venlafaxine Teva. Taking similar medicines (SSRIs) during pregnancy may increase the risk of serious complications in the newborn, called persistent pulmonary hypertension of the newborn (PPHN), which is characterized by rapid breathing and blue discoloration. These symptoms usually appear within the first day of life. If such symptoms occur in the newborn, you should immediately contact the midwife and/or doctor.
Taking Venlafaxine Teva at the end of pregnancy may increase the risk of severe vaginal bleeding shortly after delivery, especially if there is a history of bleeding disorders in the patient. If you are taking Venlafaxine Teva, you should inform your doctor or midwife so that they can provide you with appropriate advice.
If you are taking this medicine during pregnancy, after the baby is born, in addition to breathing difficulties, the baby may experience other symptoms, such as problems with sucking. If you are concerned about such symptoms in your newborn, you should contact your doctor and/or midwife, who will be able to provide you with proper advice.
Venlafaxine Teva passes into breast milk. There is a risk of affecting the baby. Therefore, you should discuss this with your doctor, and your doctor will decide whether to stop breastfeeding or stop treatment with this medicine.

Driving and using machines

You should not drive or operate machinery until you know how the medicine affects you.

Venlafaxine Teva contains sucrose

If you have been diagnosed with intolerance to some sugars, you should contact your doctor before taking this medicine.

3. How to take Venlafaxine Teva

This medicine should always be taken exactly as your doctor has told you. If you are not sure, you should ask your doctor or pharmacist.
Usually, the recommended initial dose for the treatment of depression, generalized anxiety disorder, social phobia is 75 mg per day. This dose may be gradually increased by your doctor if necessary, up to a maximum dose of 375 mg per day in the case of depression. In the case of panic disorder, treatment should be started with a lower dose (37.5 mg) and then gradually increased. The maximum dose for the treatment of generalized anxiety disorder, social phobia, and panic disorder is 225 mg per day.
Venlafaxine Teva should be taken orally.
Venlafaxine Teva should be taken daily at approximately the same time, regardless of whether the medicine is taken in the morning or evening. To ensure that the pellets (granules inside the capsules) are swallowed completely, the capsules should be swallowed whole, with a drink of water, and not opened, crushed, chewed, or dissolved.
Venlafaxine Teva should be taken with food.
If you have liver or kidney problems, you should inform your doctor, as there may be a need to adjust the dose.
Do not stop taking this medicine without consulting your doctor (see "Stopping Venlafaxine Teva treatment").

Taking a higher dose of Venlafaxine Teva than recommended

If you have taken more than the recommended dose of the medicine, you should immediately contact your doctor or pharmacist.
Overdose can be life-threatening, especially when taken with alcohol and/or certain medicines (see "Venlafaxine Teva and other medicines").
Symptoms of possible overdose may include rapid heart rate, changes in consciousness (from drowsiness to coma), changes in vision, seizures, and vomiting.

Missing a dose of Venlafaxine Teva

If you forget to take a dose, you should take it as soon as possible. However, if it is almost time for your next dose, you should skip the missed dose and take only one dose at the usual time. Do not take a double dose of Venlafaxine Teva in one day, more than the daily dose of Venlafaxine Teva prescribed by your doctor.

Stopping Venlafaxine Teva treatment

You should not stop treatment or reduce the dose of the medicine without consulting your doctor, even if you feel better. If your doctor decides that you can stop taking Venlafaxine Teva, they will tell you how to gradually reduce the dose before completely stopping treatment. When stopping this medicine, especially if treatment is stopped abruptly or the dose is reduced too quickly, side effects may occur. Some patients may experience symptoms such as suicidal thoughts, aggressive behavior, fatigue, dizziness, headache, insomnia, nightmares, dry mouth, loss of appetite, nausea, diarrhea, nervousness, restlessness, disorientation, ringing in the ears, tingling or numbness, weakness, sweating, seizures, or flu-like symptoms, and changes in vision and increased blood pressure (which can cause headache, dizziness, ringing in the ears, sweating, etc.).
Your doctor will advise you on how to gradually stop taking Venlafaxine Teva. This may take several weeks or months. In some patients, it may be necessary to stop the medicine very gradually over a period of months or longer. If you experience any of the symptoms mentioned above or other symptoms that are troublesome to you, you should consult your doctor.
If you have any further questions about taking this medicine, you should ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following side effects, you should stop taking Venlafaxine Teva and immediately contact your doctor or go to the emergency department of the nearest hospital:

Uncommon (may affect up to 1 in 100 people)

• swelling of the face, lips, tongue, throat, hands, or feet, and (or) a swollen, itchy rash (hives), difficulty swallowing or breathing.

Rare (may affect up to 1 in 1,000 people)

• chest pain, wheezing, difficulty swallowing or breathing
• severe skin rash, itching, or hives (swelling with a red or pale color, often accompanied by itching)
• symptoms of serotonin syndrome, such as: restlessness, hallucinations, loss of coordination, rapid heart rate, elevated body temperature, rapid changes in blood pressure, overreactivity, diarrhea, coma, nausea, vomiting. The most severe form of serotonin syndrome can resemble neuroleptic malignant syndrome. Its symptoms include: fever, rapid heart rate, sweating, muscle stiffness, disorientation, increased muscle enzyme levels (detected in a blood test).
• symptoms of infection, such as high temperature, chills, shivering, headache, sweating, flu-like symptoms. This may be the result of a blood disease that increases the risk of infection.
• severe skin rash, which can lead to the formation of severe blisters and skin peeling
• muscle pain of unknown origin, tenderness, or weakness. These may be symptoms of rhabdomyolysis.

Frequency not known (cannot be estimated from the available data)

• Symptoms of a condition called stress cardiomyopathy (or "broken heart syndrome"), including: chest pain, shortness of breath, dizziness, fainting, irregular heartbeat.

You should tell your doctorif you experience other side effects, such as (the frequency of these side effects is listed below in the "Other side effects" section):

• cough, wheezing, shortness of breath, which may be accompanied by high temperature
• black (tar-like) stools or blood in the stool
• yellowing of the skin or eyes, or dark urine, which may be symptoms of liver inflammation
• heart rhythm disorders, such as rapid or irregular heartbeat, increased blood pressure
• eye disorders, such as blurred vision, dilated pupils
• nervous system disorders, such as dizziness, tingling, coordination disorders (muscle spasms or stiffness), seizures or convulsions
• psychiatric disorders, such as excessive restlessness and feeling unnatural excitement
• withdrawal symptoms (see sections "How to take Venlafaxine Teva" and "Stopping Venlafaxine Teva treatment")
• Prolonged bleeding time - in case of a cut, the wound may bleed slightly longer than usual.

Other side effects

Very common (may affect more than 1 in 10 people)

• dizziness, headache, drowsiness
• insomnia
• nausea, dry mouth, constipation
• sweating (including night sweats)

Common (may affect up to 1 in 10 people)

• decreased appetite
• feeling confused, feeling detached (or separated) from oneself, lack of orgasm, decreased libido, excitement, nervousness
• tremors, feeling restless or unable to sit or stand still, tingling, taste disorders, increased muscle tone
• vision disorders, including blurred vision, dilated pupils
• ringing in the ears (tinnitus)
• rapid heartbeat, palpitations
• increased blood pressure, hot flashes
• shortness of breath, yawning
• vomiting, diarrhea
• mild rash, itching
• increased frequency of urination, urinary retention, difficulty urinating
• menstrual disorders, such as heavy bleeding or more frequent irregular bleeding; ejaculation or orgasm disorders (men), erectile dysfunction (impotence)
• weakness (asthenia), fatigue, chills
• weight gain, weight loss
• increased cholesterol levels

Uncommon (may affect up to 1 in 100 people)

• excessive activity, racing thoughts, and decreased need for sleep (mania)
• hallucinations, feeling detached (or separated) from reality, orgasm disorders, lack of feelings or emotions, feeling overly excited, teeth grinding
• fainting, involuntary muscle movements, coordination and balance disorders
• dizziness (especially when standing up too quickly), decreased blood pressure
• blood in the vomit, black (tar-like) stools (feces) or blood in the stool, which may be a sign of internal bleeding,
• increased sensitivity to light, bruising, excessive hair loss
• uncontrolled urination
• stiffness, muscle spasms, and involuntary muscle movements
• slight changes in liver enzyme activity in the blood

Rare (may affect up to 1 in 1,000 people)

• seizures
• cough, wheezing, shortness of breath, which may be accompanied by high temperature
• excessive water intake (known as SIADH)
• decreased sodium levels in the blood
• severe eye pain and vision disorders or blurred vision
• severe abdominal or back pain (which may indicate severe intestinal, liver, or pancreatic disorders)
• itching, yellowing of the skin or eyes, or dark urine, which may be symptoms of liver inflammation
• disorientation and confusion, often with accompanying hallucinations (delirium)
• abnormal, rapid, or irregular heartbeat, which can lead to fainting

Very rare (may affect up to 1 in 10,000 people)

• prolonged bleeding, which may be a sign of decreased platelet count, indicating an increased risk of bruising or bleeding
• unusual milk secretion in women
• unexpected bleeding, such as bleeding from the gums, blood in the urine or vomit, or the appearance of unexpected bruising or broken blood vessels (broken veins)

Frequency not known (cannot be estimated from the available data)

• suicidal thoughts and behaviors: during venlafaxine treatment or shortly after stopping treatment, there have been reports of suicidal thoughts and behaviors (see section 2 "Important information before taking Venlafaxine Teva")
• aggressive behavior
• vertigo of vestibular origin
• severe vaginal bleeding shortly after delivery (postpartum hemorrhage), see additional information in subsection "Pregnancy and breastfeeding" in section 2.

Venlafaxine Teva may sometimes cause side effects that you are not aware of, such as increased blood pressure or abnormal heart function; slight changes in sodium, cholesterol, or liver enzyme levels in the blood. More rarely, Venlafaxine Teva may affect platelet function, leading to an increased risk of bruising or bleeding. Therefore, your doctor may recommend a blood test from time to time, especially during long-term treatment with Venlafaxine Teva.

Reporting side effects

If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Venlafaxine Teva

The medicine should be stored out of sight and reach of children.
Do not use Venlafaxine Teva after the expiry date stated on the carton and blister after EXP. The expiry date refers to the last day of the month.
Store below 30°C.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Venlafaxine Teva contains

The active substance of the medicine is venlafaxine.
Venlafaxine Teva, 37.5 mg:
Each prolonged-release capsule contains venlafaxine hydrochloride, equivalent to 37.5 mg of venlafaxine.
Venlafaxine Teva, 75 mg:
Each prolonged-release capsule contains venlafaxine hydrochloride, equivalent to 75 mg of venlafaxine.
Venlafaxine Teva, 150 mg:
Each prolonged-release capsule contains venlafaxine hydrochloride, equivalent to 150 mg of venlafaxine.
The other ingredients are:
Capsule contents: Sucrose, pellets (sucrose + cornstarch), hypromellose, type 2910, ethylcellulose, type B, talc.
Capsule shell:
Venlafaxine Teva, 37.5 mg:
Black iron oxide (E 172), titanium dioxide (E 171), gelatin, red iron oxide (E 172)
Venlafaxine Teva, 75 mg:
Red iron oxide (E 172), titanium dioxide (E 171), gelatin
Venlafaxine Teva, 150 mg:
Yellow iron oxide (E 172), titanium dioxide (E 171), gelatin, red iron oxide (E 172)
Ink: shellac, propylene glycol, concentrated ammonia solution, black iron oxide (E172), potassium hydroxide

What Venlafaxine Teva looks like and contents of the pack

Venlafaxine Teva 37.5 mg:
Hard capsules with a non-transparent, gray cap and a non-transparent, pink body, filled with white to beige microgranules. The capsules are marked with black ink on the cap with the inscription "VNL" and on the body with "37.5". Dimensions: approximately 16 mm x 6 mm
Venlafaxine Teva 75 mg:
Hard capsules with a non-transparent, pink cap and a non-transparent, pink body, filled with white to beige microgranules. The capsules are marked with black ink on the cap with the inscription "VNL" and on the body with "75". Dimensions: approximately 20 mm x 7 mm.
Venlafaxine Teva 150 mg:
Hard capsules with a non-transparent, brown cap and a non-transparent, brown body, filled with white to beige microgranules. The capsules are marked with black ink on the cap with the inscription "VNL" and on the body with "150". Dimensions: approximately 24 mm x 8 mm.
Blisters containing: 10, 14, 20, 28, 30, 50, 98, and 100 prolonged-release, hard capsules or single-dose blisters containing 100x1 prolonged-release, hard capsules.
Not all pack sizes may be marketed.

Marketing authorization holder

Teva B.V.
Swensweg 5
2031 GA Haarlem
Netherlands

Manufacturer

Teva Pharma S.L.U.
C/C, n. 4, Poligono Industrial Malpica
50016 Zaragoza,
Spain
Teva Operations Poland Sp. z o.o.
ul. Mogilska 80,
31-546 Kraków

To obtain more detailed information on this medicine, you should contact the representative of the marketing authorization holder:

Teva Pharmaceuticals Polska Sp. z o.o., ul. Emilii Plater 53, 00-113 Warszawa, tel. (22) 345 93 00.

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Austria:
Venlafaxin Actavis
Bulgaria:
Лароксин XR
Croatia: Velafax XL
Denmark:
Venlafaxin Teva
Laroxin XR
Finland:
Venlafaxin ratiopharm
France:
VENLAFAXINE TEVA LP
Netherlands:
Venlafaxine retard Teva
Iceland;
Venlafaxin Teva
Luxembourg: Venlafaxin-ratiopharm
Germany:
Venlafaxin-ratiopharm
Norway: Venlafaxin Teva
Poland:
Venlafaxine Teva
Portugal: Venlafaxina ratiopharm
Sweden:
Venlafaxin Teva
Italy:
Venlafaxina Teva

Date of last revision of the leaflet: June 2024